Suppr超能文献

精神分裂症患者皮质5-羟色胺能系统的改变:一项尸检研究

Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.

作者信息

Gurevich E V, Joyce J N

机构信息

Christopher Center for Parkinson's Disease Research, Sun Health Research Institute, Sun City, Arizona 85372, USA.

出版信息

Biol Psychiatry. 1997 Oct 1;42(7):529-45. doi: 10.1016/S0006-3223(97)00321-1.

Abstract

Previous studies have suggested a disturbance in the cortical serotonergic (5-HT) system in schizophrenia; however, these studies have been confounded by suicide in the patients groups, which in itself is associated with alterations in the 5-HT system. In this study we characterized various components of the 5-HT system in 14 areas of the frontal and parietal cortex in tissue obtained at postmortem from aged chronically hospitalized nonsuicidal schizophrenics compared to age-matched controls. We found no differences between control and schizophrenic subjects in the density of 5-HT uptake sites or other markers of 5-HT innervation. In Brodmann areas 24 and 6 the concentration of 5-HT2A,C receptors was decreased in all schizophrenics regardless of their antipsychotic treatment history. In all other areas examined 5-HT2A,C receptor concentrations were dramatically decreased in schizophrenics patients on drugs at time of death, whereas those off drugs at death showed the same values as control subjects. The density of 5-HT1A receptors was increased in areas 24, 9a (caudal part of area 9), 44, and 6 in subjects with schizophrenia. Antipsychotic treatment did not appear to have a significant effect. Thus, the specific pattern of alterations in the 5-HT system in schizophrenia may depend on the patient population and on antemortem antipsychotic treatment. These data also provide evidence that regulation of the 5-HT2 receptor may be involved in antipsychotic action.

摘要

以往的研究提示精神分裂症患者存在皮质5-羟色胺能(5-HT)系统紊乱;然而,这些研究因患者组中的自杀行为而受到干扰,自杀本身就与5-HT系统的改变有关。在本研究中,我们对长期住院的老年非自杀性精神分裂症患者死后获取的额叶和顶叶皮质14个区域中5-HT系统的各个成分进行了特征分析,并与年龄匹配的对照组进行比较。我们发现对照组和精神分裂症患者在5-HT摄取位点密度或5-HT神经支配的其他标志物方面没有差异。在布罗德曼24区和6区,无论抗精神病治疗史如何,所有精神分裂症患者的5-HT2A、C受体浓度均降低。在所有其他检查区域,死亡时正在服药的精神分裂症患者的5-HT2A、C受体浓度显著降低,而死亡时未服药的患者其受体浓度与对照组相同。精神分裂症患者24区、9a区(9区尾部)、44区和6区的5-HT1A受体密度增加。抗精神病治疗似乎没有显著影响。因此,精神分裂症患者5-HT系统改变的特定模式可能取决于患者群体和生前抗精神病治疗情况。这些数据也提供了证据表明5-HT2受体的调节可能参与抗精神病作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验